CTOs on the Move

Manning Regional Healthcare Center

www.mrhcia.com

 
As part of the Manning Regional Healthcare Center`s comprehensive total health care system, the Hospital has state-of-the-art diagnostic radiology equipment, emergency department care, inpatient medical and surgical treatment and skilled nursing services. All of this and much more allows us to care for the majority of your medical needs right here in Manning.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.mrhcia.com
  • 1550 6th Street
    Manning, IA USA 51455
  • Phone: 712.655.2072

Executives

Name Title Contact Details
B.J. Schreck
Director of Information Technology Profile

Similar Companies

Care Access Health Plan

Care Access Health Plan is a Hallandale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wilson Ophthalmic Corp

Wilson Ophthalmic Corp is a Mustang, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alpha Source

Alpha Source is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Calhoun Vision

Calhoun Vision is focused on developing vision correction technologies for post-cataract surgery patients.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.